2021 - Participating Startup Companies
Ciscovery Bio Inc
Ciscovery Bio is a Philadelphia-based, Rutgers University spinoff that was founded in 2019. We discover and commercialize a large number of gene regulatory DNA elements named CRMs in the non-coding genome for drug development and treatment. CRMs are collectively used as biomarkers to comprehensively detect cellular changes for drug screening and individually used to control the expression of a transgene for gene therapy. Through our service, drug discovery companies can eliminate unwanted candidates (i.e., toxic or low-efficacy drugs) with high accuracy, precision medicine companies can better predict personal variation in drug response, and gene therapy companies can achieve more targeted expression of transgenes to minimize off-target effects.